Fig. 6D shows that both TQ (p < 0.05) and bortezomib (p < 0.05) alone significantly downregulated the expression of Ki-67 in MM tumor tissues and the combination of the two was even more effective (p < 0.05). The gene discussed is MKI67; the disease is Miyoshi myopathy.